Taysha Gene Therapies, Inc.TSHANASDAQ
Loading
Cost of Revenue Over TimeStrong
Percentile Rank83
3Y CAGR-38.3%
5Y CAGR+130.5%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
-38.3%/yr
Annual compound
5Y CAGR
+130.5%/yr
Recent deceleration
Percentile
P83
Within normal range
vs 5Y Ago
65x
Strong expansion
Streak
1 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $585000.00 | - |
| 2024 | $0.00 | - |
| 2023 | $0.00 | -100.0% |
| 2022 | $2.49M | - |
| 2021 | $0.00 | -100.0% |
| 2020 | $9000.00 | - |
| 2019 | $0.00 | - |